| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. | Mol Cell Proteomics | 2005 | 2.66 |
| 2 | Differential and epigenetic gene expression profiling identifies frequent disruption of the RELN pathway in pancreatic cancers. | Gastroenterology | 2006 | 1.55 |
| 3 | Protection of hippocampal neurogenesis from toll-like receptor 4-dependent innate immune activation by ablation of prostaglandin E2 receptor subtype EP1 or EP2. | Am J Pathol | 2009 | 0.94 |
| 4 | Suppressed retinal degeneration in aged wild type and APPswe/PS1ΔE9 mice by bone marrow transplantation. | PLoS One | 2013 | 0.79 |
| 5 | Tumor molecular profiling in the treatment of refractory cancers. | J Exp Ther Oncol | 2015 | 0.75 |